Recurrent Implantation Failure: Why It's Often a Couple-Based Problem

After a third failed embryo transfer, most couples ask the same question in a different order: "Is it me, or is it him?" The honest answer, more often than clinicians once assumed, is both.

Recurrent implantation failure, commonly shortened to RIF, is usually investigated as if the cause lives in one partner. Endometrial thickness gets checked. Egg quality gets discussed. But a growing body of research shows that recurrent implantation failure frequently involves a combination of factors from both partners working together, not a single isolated problem.

According to the European Society of Human Reproduction and Embryology (ESHRE), recurrent implantation failure disturbs roughly one in ten couples going through IVF and embryo transfer. It's an emotionally exhausting experience, and understanding it as a couple-based issue, rather than pinning it on one partner, can change both the investigation and the treatment plan.

This guide walks through what recurrent implantation failure actually means, why couple-based causes matter, how they're investigated, and what current evidence actually supports, rather than what's simply popular in fertility clinics.

---

What Is Recurrent Implantation Failure, Exactly?

There's no single universally agreed definition, which itself has been a challenge in this field. ESHRE published good practice recommendations in 2023 specifically to address this gap, focusing on identifying the chance of successful implantation for the individual patient or couple rather than applying a rigid embryo-count formula.

A commonly used working definition describes RIF as failure to achieve a clinical pregnancy after transferring at least four good-quality embryos across a minimum of three cycles, in a woman under 40. Maternal age matters enormously here since pregnancy rates naturally decline with age, so any definition of RIF has to account for it.

Why "Couple-Based" Matters

For years, implantation failure investigations leaned heavily toward the female partner: endometrial lining, hormone levels, uterine anatomy. But embryo quality depends on genetic material from both partners, and a growing body of evidence points to contributing factors on the male side too.

Recurrent implantation failure can involve:

• Embryo-related factors (often linked to genetic material from both egg and sperm)
• Endometrial or uterine factors
• Immunological and clotting-related factors
• Male-partner sperm quality factors
• Shared lifestyle factors like BMI in either or both partners

---

Couple-Based Causes of Recurrent Implantation Failure

1. Embryo Aneuploidy — A Shared Contribution

Embryonic chromosomal abnormality (aneuploidy) is considered the single most common reason for implantation failure once other known factors are excluded. Aneuploidy can originate from the egg, the sperm, or errors during early embryo division, meaning it isn't automatically a "female factor" issue.

Research has found that men with higher sperm aneuploidy rates showed worse clinical outcomes in ICSI cycles, and increased sperm DNA damage has been associated with higher embryo aneuploidy risk in some RIF patients. This is still an evolving area, and not every study agrees on the strength of this link.

2. Parental Chromosomal Rearrangements

In a smaller number of couples, one partner carries a balanced chromosomal rearrangement, a structural change that causes no health issues for the carrier but can lead to embryos with unbalanced chromosomes. This is identified through karyotype testing of both partners and is one of the more clearly established genetic contributors when present.

3. Sperm DNA Fragmentation — A Genuinely Mixed Picture

This deserves an honest, balanced explanation rather than a simple yes-or-no answer. Some studies link elevated sperm DNA fragmentation (SDF) to recurrent implantation failure and pregnancy loss, since damaged sperm chromatin may contribute to abnormal embryo development. Certain clinical practice guidelines recommend SDF testing for unexplained infertility or recurrent pregnancy loss, though at a modest evidence grade.

However, other well-designed studies have found no significant difference in sperm DNA fragmentation between couples with RIF and fertile controls, and no consistent link between SDF and embryo aneuploidy in RIF patients specifically. In short: sperm DNA fragmentation is a reasonable factor to investigate in select cases, but it isn't a confirmed universal cause, and results should be interpreted cautiously alongside other findings.

4. Endometrial and Uterine Factors

While this guide focuses on couple-based causes, endometrial receptivity, chronic endometritis, and uterine structural abnormalities remain important pieces of the puzzle and are typically evaluated alongside male-partner factors, not instead of them.

5. Shared Lifestyle Factors

A lifestyle review is recommended as part of RIF evaluation, and body mass index (BMI) is specifically highlighted as a factor worth assessing in this context. Elevated BMI in either partner has been linked to lower implantation and pregnancy success in various studies, making weight management a genuinely shared consideration rather than one partner's responsibility alone.

Comparing Couple-Based Contributing Factors

---

How Couple-Based Causes Are Investigated

ESHRE's good practice recommendations specifically caution against ordering every available test without a clear rationale, since many popular RIF investigations, including some immunological panels, lack strong evidence supporting their routine use. A focused, evidence-guided workup typically includes:

• Karyotype testing for both partners, particularly relevant after multiple failed transfers or pregnancy losses
• Semen analysis, and selectively, sperm DNA fragmentation testing when there's a specific clinical indication
• Uterine cavity assessment (ultrasound, hysteroscopy) to rule out structural issues
• Endometrial evaluation, including screening for chronic endometritis where indicated
• Lifestyle and BMI review for both partners
• Embryo genetic testing (PGT-A), considered in specific situations to assess chromosomal status directly

Not every test applies to every couple. Your fertility specialist should tailor the workup based on your specific history, rather than running a blanket panel of tests with uncertain benefit.

---

Treatment Approaches for Couple-Based RIF

Treatment naturally follows from what's found during investigation, and it often involves both partners.

• When sperm DNA fragmentation is elevated, treatment may include ICSI with carefully selected sperm, addressing underlying causes like infection or lifestyle factors, or in select cases, using testicular sperm extraction.
• When a chromosomal rearrangement is identified, options include preimplantation genetic testing for structural rearrangements (PGT-SR) to select embryos more likely to be chromosomally balanced.
• When embryo aneuploidy is suspected as a broader issue, PGT-A may be discussed to help select embryos with a normal chromosome number before transfer.
• When BMI is a contributing factor, a structured weight management plan for either or both partners may be recommended before further transfers.
• When no clear couple-based cause is found, ESHRE's guidance still emphasizes restraint: pursuing only interventions with a clear rationale rather than adding unproven treatments in the hope that something helps.

Most couples with recurrent implantation failure do eventually achieve a pregnancy after appropriate investigation and treatment, though prognosis is closely tied to maternal age and the specific cause identified. A personalized plan from a fertility specialist matters more than any single test result in isolation.

---

Key Takeaways

• Recurrent implantation failure affects roughly 1 in 10 couples undergoing IVF and often involves both partners, not just one.
• Embryo aneuploidy, arising from egg, sperm, or early division errors, is considered the most common underlying cause.
• Parental chromosomal rearrangements and sperm DNA fragmentation are recognized couple-based factors, though evidence for sperm DNA fragmentation specifically is mixed.
• Current ESHRE guidance recommends a focused, evidence-based workup rather than broad, unproven testing panels.
• BMI and lifestyle factors in either partner are a legitimate, modifiable part of the picture.
• A fertility specialist should guide testing and treatment based on your specific history; this article is educational, not a diagnosis.

---

Frequently Asked Questions

1. Is recurrent implantation failure always the woman's fault? No. Research increasingly shows that male-partner factors, including sperm DNA quality and chromosomal issues, can contribute meaningfully. Embryo aneuploidy, the most common cause, can originate from either the egg or the sperm.

2. How many failed embryo transfers count as recurrent implantation failure? There's no single universal number, but a commonly used definition involves failure to achieve pregnancy after transferring at least four good-quality embryos across three or more cycles in a woman under 40. Your specialist will consider your specific age and history.

3. Does sperm DNA fragmentation testing help diagnose RIF? Sometimes, but the evidence is mixed. Some studies link elevated fragmentation to implantation failure, while others find no significant difference compared to fertile couples. It's generally recommended selectively rather than as a routine test for everyone.

4. Should both partners get karyotype testing? Often, yes, particularly after multiple failed transfers or pregnancy losses. A balanced chromosomal rearrangement in either partner, while uncommon, can meaningfully affect embryo chromosome numbers and is identified through this test.

5. Can weight affect implantation success? Yes. Elevated BMI in either partner has been associated with lower implantation and pregnancy rates in various studies, and lifestyle review is specifically recommended as part of RIF evaluation for both partners.

6. Are immunological tests like NK cell testing helpful for RIF? Current ESHRE good practice guidance specifically cautions against routinely ordering tests, including some immunological panels, that lack strong supporting evidence. Discuss with your specialist whether a specific test has a clear rationale for your situation before proceeding.

7. What is PGT-A and does it help with RIF? Preimplantation genetic testing for aneuploidy (PGT-A) screens embryos for chromosomal abnormalities before transfer. It's considered in specific RIF situations to help select chromosomally normal embryos, though it doesn't guarantee implantation success on its own.

8. Can male-factor treatment improve outcomes in RIF? In couples where sperm DNA fragmentation or other male-factor issues are identified, treatment approaches like ICSI with careful sperm selection, addressing infection, or lifestyle changes may improve outcomes, though results vary by individual case.

9. Is there a cure for recurrent implantation failure? There's no universal cure, since RIF has multiple possible causes. However, most couples do achieve pregnancy after a targeted investigation identifies and addresses the specific contributing factor, whether that's embryo-related, uterine, or lifestyle-based.

10. How long should we keep trying before seeking specialized RIF evaluation? This depends on your age, embryo quality, and number of prior attempts, and is best discussed individually. Many specialists recommend a focused evaluation after two to three failed transfers with good-quality embryos, rather than continuing without investigation.

---

Final Thoughts

Recurrent implantation failure is rarely about just one partner. Increasingly, the evidence points toward a shared picture, egg, sperm, embryo, uterus, and lifestyle factors, that's best investigated as a couple rather than through one partner's test results alone.

If you and your partner have experienced repeated failed transfers, a focused, evidence-based evaluation of both partners is a reasonable next step, guided by a fertility specialist familiar with current recommendations.

This article is for general educational purposes and does not replace personalized medical advice. Please consult a qualified fertility specialist at Urvara Fertility Centre to evaluate your specific situation.